Empty Capsules Market Size

Empty Capsules Market size was valued at USD 2.89 Billion in 2023 and is poised to grow from USD 3.09 Billion in 2024 to USD 5.31 Billion by 2032, growing at a CAGR of 7% during the forecast period (2025-2032).

Investing in the development of empty capsules with different raw materials to satisfy different consumer demands will provide new business scope for empty capsules companies. Targeting emerging countries with increasing sales of supplements and pharmaceuticals will be a key strategy for all empty capsules providers. New product launches and collaborations are slated to be preferred strategies for empty capsules companies looking to enhance their overall market presence. 'Capsugel', 'ACG Worldwide', 'Suheung Co., Ltd.', 'Qualicaps, Inc.', 'Lonza Group Ltd.', 'Farmacapsulas S.A.', 'Medi-Caps Ltd.', 'Roxlor LLC', 'Snail Pharma Industry Co., Ltd.', 'Nectar Lifesciences Ltd.', 'Sunil Healthcare Ltd.', 'Bright Pharma Caps, Inc.', 'Natural Capsules Ltd.', 'JC Biological Technology Co., Ltd.', 'Shanxi Guangsheng Medicinal Capsule Co., Ltd.', 'Healthcaps India Limited', 'CapsCanada Corporation', 'Lefancaps® Capsule', 'Healsee Capsule Co., Ltd.', 'Shanghai Honglian Medical Tech Group Co., Ltd.'

Consumption of dietary supplements, nutraceuticals, and pharmaceuticals is increasing around the world owing to high prevalence of chronic diseases and rising health consciousness. Use of empty capsules for the delivery of these nutraceuticals and drugs will promote empty capsules market growth in the future.  

Vegan and Plant-based Capsules: Most capsules used currently are made from synthetic or animal-based materials. As the empty capsules market trend & popularity of veganism and plant-based food products increases around the world it is also expected to create new opportunities for empty capsules companies using plant-based materials for their offerings going forward.    

North America is projected to account for a dominant global empty capsules market share. Presence of key pharmaceutical companies, growing demand for novel drugs, and increasing prevalence of chronic diseases are key factors that help this region hold a dominant stance. The United States and Canada are slated to emerge as the most opportune markets in this region through 2031. High spending potential of consumers in this region will also play a critical role in driving the demand for empty capsules.